Icon

NORLIQVA (nda214439)- (EQ 1MG BASE/ML)

AMLODIPINE BESYLATE CMP DEV LLC
EQ 1MG BASE/ML
No Yes
2041-Feb-24 Expired
None None
None No
NORLIQVA is a calcium channel blocker for the treatment of: • Hypertension o NORLIQVA is indicated for the treatment of hypertension in adults and children 6 years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. • Coronary Artery Disease o Chronic Stable Angina o Vasospastic Angina (Prinzmetal's or Variant Angina) o Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction <40%.
0 0 0
Total Other Developers 3
Drugs with Suitability No
EQ 1MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.